Table 1.
Baseline characteristics of enrolled patients
| Characteristics | Total patients (%) | Conversion surgery (%) |
|---|---|---|
| n = 30 | n = 11 | |
| Sex | ||
| Male | 14 (46.7%) | 5 (45.5%) |
| Female | 16 (53.3%) | 6 (54.5%) |
| Age (years) | ||
| Median | 51 | 41 |
| Range | 29–74 | 29–74 |
| ECOG score | ||
| 0–1 | 28 (93.3%) | 11 (100%) |
| 2 | 2 (6.7%) | 0 (0) |
| Previous chemotherapy | ||
| Yes | 7 (23.3%) | 0 (0) |
| No | 23 (76.7%) | 11 (100%) |
| Histological type | ||
| Poorly differentiated adenocarcinoma | 22 (73.3%) | 6 (54.5%) |
| Signet ring cell carcinoma | 8 (26.7%) | 5 (45.5%) |
| Lauren’s type | ||
| Intestinal | 11 (36.7%) | 4 (36.7%) |
| Diffuse | 19 (63.7%) | 7 (63.7%) |
| Extent of peritoneal metastases | ||
| P2 | 4 (13.3%) | 2 (18.2%) |
| P3 | 26 (86.7%) | 9 (81.8%) |
| Ascites | ||
| Yes | 23 (76.7%) | 7 (63.6%) |
| No | 7 (23.3%) | 4 (36.4%) |
| PCI score | ||
| 0–9 | 5 (16.7%) | 3 (27.3%) |
| 10–19 | 8 (26.7%) | 5 (45.4%) |
| 20–39 | 17 (56.6%) | 3 (27.3%) |
| Ovary metastasis | ||
| Yes | 7 (23.3%) | 3 (27.3%) |
| No | 23 (76.7%) | 8 (72.7%) |